If other companies are unable to replicate Bene's PPS I highly doubt PAR will be able to. From memory, Bene's PPS also goes through a processing step to synthetically modify the compounds, which might explain why it may function differently to other PPS preparations. Let's just say it might be easier (and less expensive) to test a new PPS product in OA than it would be to replicate Bene's product.
research reports and media, page-3865
-
- There are more pages in this discussion • 586 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 99346 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 131244 | 5 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |